Physician profile
Elise Simpson
NPI 1972949220
$4,220.13
in general payments reported to CMS, 2019-2025
33 companies · $517 in 2025
The $517 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,542 · 2020: $138 · 2021: $322 · 2022: $634 · 2023: $653 · 2024: $415 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.41 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,457.53 | 2019 | |
| Aspira Women'S Health INC | $547.60 | 2021-2024 | Ova1 |
| Abbvie INC. | $314.42 | 2019-2025 | Liletta, Orilissa |
| Astellas Pharma US INC | $193.46 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $185.99 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $182.01 | 2019-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $122.50 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.09 | 2020-2025 | |
| Sage Therapeutics, LLC | $116.38 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $96.03 | 2023-2025 | Myfembree |
| Pfizer INC. | $91.45 | 2023-2025 | |
| Organon LLC | $86.67 | 2022-2025 | Nexplanon |
| Myriad Women'S Health, INC. | $80.57 | 2023 | Myrisk |
| Amgen INC. | $65.31 | 2020-2024 | Evenity, Prolia |
| Mylan Pharmaceuticals INC. | $65.00 | 2020-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $57.18 | 2019-2025 | Paragard T 380a |
| Exact Sciences Corporation | $53.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $43.15 | 2019-2024 | Gardasil, Gardasil 9 |
| Daiichi Sankyo INC. | $42.23 | 2022-2023 | Injectafer |
| Gynesonics, INC. | $39.05 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $38.25 | 2022 | |
| Myovant Sciences INC. | $28.83 | 2022 | |
| Smith+Nephew, INC. | $21.49 | 2022 | |
| Boston Scientific Corporation | $21.13 | 2019 | |
| Millicent US INC | $20.47 | 2025 | Femlyv |
| Mimedx Group, INC. | $19.91 | 2024 | |
| Amag Pharmaceuticals, INC. | $18.77 | 2022 | |
| Channel Medsystems, INC. | $17.21 | 2023 | |
| Supernus Pharmaceuticals, INC. | $16.74 | 2025 | Qelbree |
| Pacira Pharmaceuticals Incorporated | $14.68 | 2023 | Exparel |
| Agile Therapeutics, INC. | $14.67 | 2023 | Twirla |
| Avation Medical, INC. | $13.95 | 2025 | Vivally System |
| Meditrina | $13.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.